29
Mar 2019
10:30
Klinikum 2, Medizinische Polyklinik, KAIM Konferenzraum #20-0-070A, Petersgraben 4, 4051 Basel
Doctoral dissertation defense
Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and the liver
Export event as
iCal